GRAIL, Inc. 8-K

What Happened
GRAIL, Inc. (GRAL) announced on January 12, 2026 that it will present a corporate update and preliminary results for the quarter and year ended December 31, 2025 at the 2026 J.P. Morgan Healthcare Conference. The company furnished the presentation to be used as Exhibit 99.1 to the Form 8-K. The filing was signed by Aaron Freidin, Chief Financial Officer.

Key Details

• Filing date: January 12, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Event: Presentation at the 2026 J.P. Morgan Healthcare Conference.
• Period covered: quarter and year ended December 31, 2025.
• Presentation is provided as Exhibit 99.1 to the Form 8-K; the 8-K itself does not disclose specific revenue or earnings figures.

Why It Matters
This filing signals that GRAIL will provide preliminary financial information and a corporate update on its 2025 performance, offering investors an early look at recent quarterly and full-year results and management’s messaging. Retail investors should review the furnished presentation (Exhibit 99.1) and any accompanying public remarks for details on revenue, earnings, guidance, or strategy changes, since the Form 8-K notice itself does not include numerical results.